Browse the latest research summaries in the field of pain management for spinal cord injury patients and caregivers.
Showing 141-150 of 682 results
Cureus, 2023 • August 16, 2023
Peripheral nerve damage and inflammation are known causes of chronic pain. Prolonged activation of sensory nerves leads to increased activity of nerve cells in the spinal cord and activation of immune...
KEY FINDING: Microglia participate in the onset, maintenance, mediation, and expansion of neuropathic pain. Inhibiting microglial cell activity in neuropathic pain models leads to milder pain.
Korean J Pain, 2023 • August 1, 2023
This systematic review and meta-analysis evaluated the efficacy of muscimol in ameliorating nerve injury-related neuropathic pain based on preclinical studies. The study found that muscimol is effecti...
KEY FINDING: Muscimol significantly reduces mechanical allodynia (SMD = 1.78 [1.45–2.11]; P < 0.0001; I2 = 72.70%), mechanical hyperalgesia (SMD = 1.62 [1.28–1.96]; P < 0.0001; I2 = 40.66%), and thermal hyperalgesia (SMD = 2.59 [1.79–3.39]; P < 0.0001; I2 = 80.33%).
Cells, 2023 • September 20, 2023
This study investigates the differential effects of regulatory T cells (Tregs) on neuropathic pain in male and female mice following peripheral nerve injury. The researchers utilized intrathecal adopt...
KEY FINDING: Intrathecal delivery of activated Tregs reduced mechanical pain hypersensitivity and improved exploratory behaviors in both male and female mice following chronic constriction injury (CCI) of the sciatic nerve.
Healthcare, 2023 • September 16, 2023
This study evaluated the effects of NACVAN®, a commercially available nutraceutical, as an add-on to gabapentinoids for treating pain in patients with central neuropathic pain (CNP) resulting from spi...
KEY FINDING: There was a significant reduction in pain intensity from baseline to 3 weeks (p = 0.021) and from baseline to 6 weeks (p = 0.011).
Int. J. Mol. Sci., 2023 • September 6, 2023
This study used a mouse chronic pain model to test the hypothesis that early exposure to the general anesthetic (GA) Isoflurane causes cellular and molecular alterations in dorsal spinal cord (DSC) and...
KEY FINDING: Early isoflurane exposure enhances sensitivity for mechanical and thermal stimuli in a chronic pain model caused by SNI.
Cureus, 2023 • September 2, 2023
Interventional procedures and drug therapy to reduce pain may introduce iatrogenic side effects. These adverse events range from those that are merely bothersome to those that reduce the quality of li...
KEY FINDING: Interventional pain procedures can lead to nerve or vascular injuries, spinal cord trauma, and epidural abscesses, though these are rare.
Neurospine, 2023 • September 1, 2023
This systematic review and meta-analysis aimed to assess the efficacy of exercise in neuropathic pain following traumatic spinal cord injuries. The meta-analysis of preclinical studies demonstrated th...
KEY FINDING: Exercise significantly improves mechanical allodynia, thermal hyperalgesia, and cold allodynia in rodent models of SCI.
The Journal of Neuroscience, 2023 • December 6, 2023
The study identifies a spinal-specific super enhancer (SS-SE) that plays a critical role in the development and maintenance of neuropathic pain. SS-SE drives the expression of Ntmt1 and Prrx2 in dorsa...
KEY FINDING: A spinal-specific super enhancer (SS-SE) was identified that regulates CCI-induced neuropathic pain by driving Ntmt1 and Prrx2 transcription in dorsal horn neurons.
Neurosci Lett., 2023 • November 20, 2023
This study investigates the effectiveness of systemic administration of NIS-lncRNA ASO in alleviating neuropathic pain (NP) in mice with chronic constriction injury (CCI). The results demonstrate that...
KEY FINDING: Systemic administration of NIS-lncRNA ASO significantly alleviated CCI-induced mechanical allodynia, heat hyperalgesia, and cold hyperalgesia in mice.
Front. Pain Res., 2023 • September 22, 2023
This review provides an overview of neuropathic pain, its causes, mechanisms, and potential treatments. It highlights the limitations of current animal models and the need for improved translational a...
KEY FINDING: Peripheral nerve injury leads to the release of primary inflammatory mediators, activating immunocompetent cells and causing neuroinflammation.